MiR-122 has also been characterized as a tumor suppressor miRNA affecting hepatocellular carcinoma intrahepatic metastasis by angiogenesis suppression, and its mode of action has been associated with the regulation of the disintegrin and metalloprotease 17 (ADAM17) [147]. The gene discussed is ADAM17; the disease is hepatocellular carcinoma.